DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Powles T, Duran I, van der Heijden MS. et al.
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.
Lancet 2017;
391 (Suppl. 24) 748-757
Access:
We do not assume any responsibility for the contents of the web pages of other providers.